Cargando…
Development of Perphenazine-Loaded Solid Lipid Nanoparticles: Statistical Optimization and Cytotoxicity Studies
OBJECTIVE: Perphenazine (PPZ), as a typical antipsychotic medical substance, has the same effectiveness compared to atypical antipsychotic medications for the treatment of schizophrenia. Despite the lipophilic essence, PPZ encounters limited bioavailability caused by the first-pass metabolism follow...
Autores principales: | Farsani, Parisa Abbasi, Mahjub, Reza, Mohammadi, Mojdeh, Oliaei, Seyed Sajad, Mahboobian, Mohammad Mehdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099510/ https://www.ncbi.nlm.nih.gov/pubmed/33997026 http://dx.doi.org/10.1155/2021/6619195 |
Ejemplares similares
-
Development of the Binary and Ternary Atorvastatin Solid Dispersions: In Vitro and In Vivo Investigations
por: Faraji, Elahe, et al.
Publicado: (2021) -
Anti-tumor effects of perphenazine on canine lymphoma
por: TSUJI, Shunya, et al.
Publicado: (2016) -
Sustained release Curcumin loaded Solid Lipid Nanoparticles
por: Jourghanian, Parisa, et al.
Publicado: (2016) -
Prolonged Drug-Drug Interaction between Terbinafine and Perphenazine
por: Park, Young-Min
Publicado: (2012) -
PLGA Biodegradable Nanoparticles Containing Perphenazine or Chlorpromazine Hydrochloride: Effect of Formulation and Release
por: Halayqa, Mohammed, et al.
Publicado: (2014)